HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FTC Targets EM Radiation ‘Blocking Patch’ Seller In Latest COVID-19 Warning Letter Salvo

Executive Summary

The Commission serves up 35 more warning letters to companies making false and unsubstantiated COVID-19 claims, including Julie E Health, which marketed a prevention and treatment kit comprised of dietary supplements and purported EMF “remediation” products, capitalizing on conspiracy theory anxieties.

You may also be interested in...



No Hiding Bogus Coronavirus Claims From US Regulators In Social Media Or With Vague Terms

“I don’t know if there’s a misconception that a different set of adverting rules apply to social media," says FTC attorney Christine DeLorme during FDLI conference. The FTC also sees "a lot of attempts at disclaimers. They might say, ‘Of course there’s no cure for COVID, but...’"

COVID-19 Fraud In US: Online Pharmacies Promote HIV Drug, Ammo Dealer Pitches Vitamin C

Latest letters from website reviews push to 62 the number of warnings the FDA, either jointly with the FTC or on its own, has made stating that no drug has yet been approved by the agency for use in the prevention, diagnosis, treatment, mitigation or cure of COVID-19.

Patch, Soap and Essential Oil Firms Warned On COVID-19 Claims, Court Silences Herbal Firm

FDA and FTC submit another three warnings to consumer health marketers making bogus claims to prevent or treat COVID-19. FTC also announces California firm agreed to court order to stop claiming a supplement consisting mainly of vitamin C and herbal extracts is an effective treatment.

Topics

UsernamePublicRestriction

Register

LL1134043

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel